Improving the pharmaceutical supply chain
Enabling intelligent pharmaceutical packaging
CPI worked as part of the UK-based ReMediES (RE-configuring MEDIcines End-to-end Supply) consortium to develop product concepts that demonstrate the potential for printable electronics in the pharmaceutical supply chain and develop technology to improve the performance of blister packaging making the commercialisation of intelligent pharmaceutical packaging possible.
An input is a unique capability, service or method of support that was provided, such as equipment or expertise.
- Facilities and equipment investment
- Technical knowledge and expertise
- Research and development
- Process validation
An output is the result of the work, such as an experimental finding, an actual product or a pilot demonstrator.
- New job creation
- Development of product concepts for smart labels
- Completion of real-world trials
- Development of a mobile phone app capable of transmitting real-time data via the Internet of Things to monitor temperature and humidity of products
An outcome arises from implementing the outputs, for example, a profit, an investment, providing jobs or delivering societal benefits. Outcomes continue once an innovation has been implemented and deliver benefit every year.
- Potential to reduce waste and more efficient supply of drugs
- Accelerated TRL of smart labelling
- Increased sector knowledge and engagement, and understanding of smart labelling
- Stronger presence within the Medicines Manufacturing Industry Partnership
- Follow on H2020 collaborative project: InScope